Edgestream Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.03M | Sell |
16,164
-686
| -4% | -$86.2K | 0.06% | 528 |
|
|
2025
Q1 | $2.31M | Sell |
16,850
-3,285
| -16% | -$450K | 0.08% | 447 |
|
|
2024
Q4 | $3.08M | Buy |
20,135
+8,917
| +79% | +$1.36M | 0.13% | 304 |
|
|
2024
Q3 | $2.17M | Buy |
11,218
+10,289
| +1,108% | +$1.99M | 0.1% | 378 |
|
|
2024
Q2 | $215K | Sell |
929
-721
| -44% | -$167K | 0.01% | 801 |
|
|
2024
Q1 | $356K | Buy |
+1,650
| New | +$356K | 0.02% | 694 |
|
|
2023
Q4 | – | Sell |
-4,386
| Closed | -$1.13M | – | 838 |
|
|
2023
Q3 | $1.13M | Buy |
+4,386
| New | +$1.13M | 0.09% | 362 |
|
|
2022
Q2 | – | Sell |
-6,375
| Closed | -$1.34M | – | 513 |
|
|
2022
Q1 | $1.34M | Sell |
6,375
-33,212
| -84% | -$7M | 0.11% | 278 |
|
|
2021
Q4 | $9.5M | Buy |
39,587
+22,373
| +130% | +$5.37M | 0.59% | 30 |
|
|
2021
Q3 | $4.87M | Buy |
17,214
+13,291
| +339% | +$3.76M | 0.3% | 110 |
|
|
2021
Q2 | $1.36M | Buy |
+3,923
| New | +$1.36M | 0.08% | 264 |
|
|
2018
Q4 | – | Sell |
-1,059
| Closed | -$374K | – | 227 |
|
|
2018
Q3 | $374K | Sell |
1,059
-5,409
| -84% | -$1.91M | 0.06% | 206 |
|
|
2018
Q2 | $1.88M | Sell |
6,468
-3,202
| -33% | -$929K | 0.38% | 98 |
|
|
2018
Q1 | $2.65M | Buy |
+9,670
| New | +$2.65M | 0.52% | 63 |
|
|
2015
Q2 | – | Sell |
-547
| Closed | -$231K | – | 108 |
|
|
2015
Q1 | $231K | Buy |
+547
| New | +$231K | 0.3% | 70 |
|
|
2014
Q3 | – | Sell |
-849
| Closed | -$268K | – | 80 |
|
|
2014
Q2 | $268K | Buy |
+849
| New | +$268K | 0.17% | 72 |
|